3^rd International Conference and Exhibition on Nanomedicine and Drug Delivery October 16-17, 2019 Singapore

Dr Ling Peng is a leading expert in developing functional dendrimer nanosystems for drug delivery in biomedical applications. She has successfully established bio-inspired structurally flexible and self-assembling dendrimer nanosystems for drug and nucleic acid delivery. One of the dendrimers developed by her team has been scheduled in clinical trials. Dr Peng has coordinated and participated in different European projects and actively involved in several European COST Actions. She is currently a research director at the French National Scientific Research Center (CNRS), and a principle investigator at the Centre Interdisciplinaire de Nanoscience de Marseille (CINaM). Her research team has been labelled by La Ligue contre Le Cancer in France, and she was awarded for the Prize of Dr and Mrs Henri Labbé by the French Academy of Sciences in 2017.

Functional dendrimer nanosystems for drug delivery in biomedical applications

Barbara Adinolfi Received The Master Degree In Pharmaceutical Chemistry And Technology In 2000 From The University Of Pisa, Italy. She Received The Phd In Pharmacotoxicological, Pharmacognostical Sciences And Pharmacological Biotechnologies In 2005 From The University Of Milan And The Specialization In Pharmacology In 2008 From The University Of Pisa. She Has Worked From 2000 Until 2013 At The Department Of Pharmacy, University Of Pisa. She Also Spent A Period (2009-2010) In The Department Of Biomedical Sciences, University Of Copenhagen. At Present She Is At The CNR Institute Of Applied Physics In Florence.

Her Research Activity Is Focused On The Evaluation Of Anticancer Activity Of Natural And Synthetic Compounds, On The Evaluation Of The Role Of Specific Proteins As Putative Prognostic Markers In Cancer And On The Activity Of Nanoparticles As Intracellular Delivery Tools For Oligonucleotide Optical Switches By Confocal Microscopy.

DR.Arend L. Mapanawang, Sp.PD, Finasim is the director of Health Medical College in Halmahera, North of Maluku, Indonesia as well as the Editor-in-Chief of International Journal of Health Medicine and Current Research (www.ijhmcr.com), Chairman International Arend Index (IAI), and International Conference on Health Medicine (ICCHM) Dr. Arend is an expert in herbal medicine including for the curing of malaria, HIV virus, and hepatitis, as well as a practical doctor for healing many other internal body parts of human being deceases with more than 20 years experiences. He had written various books including history and the cause of world wars books. His publications in various international journals have made him as a prominent invited speaker in the world such as in South Korea, United Kingdom, and USA.

Herbal medicine including for the curing of malaria, HIV virus, and hepatitis

Virendra Gajbhiye completed his M. Pharm and Ph.D. from Dr. H. S. Gour University, Sagar, India. He was a postdoctoral research fellow at Wisconsin Institute for Discovery, University of Wisconsin, Madison, WI, USA and Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA. Currently, he is working as a Scientist at Nanobioscience Group, Agharkar Research Institute, Pune, India. Virendra Gajbhiye has his expertise in developing multifunctional nanocarriers and their use in nanomedicine and theranostics, targeted delivery of drug/siRNA/miRNA for cancer therapy, and tissue engineering. He has extensively worked on drug targeting to brain.

Delivery of siRNA/miRNA for treatment of breast cancer

Virendra Gajbhiye completed his M. Pharm and Ph.D. from Dr. H. S. Gour University, Sagar, India. He was a postdoctoral research fellow at Wisconsin Institute for Discovery, University of Wisconsin, Madison, WI, USA and Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA. Currently, he is working as a Scientist at Nanobioscience Group, Agharkar Research Institute, Pune, India. Virendra Gajbhiye has his expertise in developing multifunctional nanocarriers and their use in nanomedicine and theranostics, targeted delivery of drug/siRNA/miRNA for cancer therapy, and tissue engineering. He has extensively worked on drug targeting to brain.

Delivery of siRNA/miRNA for treatment of breast cancer

Dr. Claudio Domenici received the Laurea degree in physics from the University of Pisa, the D.E.A. degree in “Optical Instrumentation” from the University of Grenoble and the PhD in “Materials Engineering” from the Politecnico of Milan. Since the 80s he has been involved in the research activities in the field of bioengineering carried out at Centro “E. Piaggio”, University of Pisa, and at the Institute of Clinical Physiology of the Italian National Research Council, where from 2001 he has been Research Director in the area “Technological and basic science for medicine”. In this field he is and has been scientific responsible of National and European research and industrial projects. He is currently involved in the national flagship project NANOMAX, addressed to nanotechnology for the development of new systems of diagnosis and therapy on the organs or directly on the patients and, in particular, he is coordinator of the project ENCODER (Engineered Nanostructures for Cellular imaging and for intracellular delivery of Optically active Drugs for cardiac hypERtrophy), which aim is to realize functionalized nanomaterials able to target molecular biomarkers of disease and, by selective drug delivery and multimodal detection, integrate imaging and therapeutic functions in a single platform (intracellular theranostics).

His scientific interest, devoted for many years to sensing in biomedical engineering, to gene specific biosensors and nanosensors, and on dynamic cell culture systems for tissue engineering, is currently focused on nanomedicine, considering the development of different complex nanostructures for therapy/sensing applications as well as for multimodal diagnosis and imaging.